Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study-Reference-Cited by-同舟云学术

Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study

Published:2011-02-17 Issue:9 Volume:27 Page:615-621
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Naka Katerina K.,Kalantaridou Sophia N.,Bechlioulis Aris,Kravariti Maria,Kazakos Nikolaos,Katsouras Christos S.,Tsatsoulis Agathocles,Michalis Lampros K

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2010.521265

Reference38 articles.

1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

2. Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights

3. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors

4. Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction

5. Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS);Early Vascular Aging (EVA);2024

2. Hirsutism, Normal Androgens and Diagnosis of PCOS;Diagnostics;2022-08-09

3. Combined oral contraceptives: Why, when, where?;Polycystic Ovary Syndrome;2022

4. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome;European Endocrinology;2021

5. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome;European Endocrinology;2021